Reply: miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR Study

被引：0

作者：

Thor, Anna ^{[1
,2
]}

机构：

[1] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Urol, S-17177 Stockholm, Sweden

[2] Karolinska Univ Hosp, Pelvic Canc, Dept Urol, Stockholm, Sweden

来源：

JOURNAL OF UROLOGY | 2025年 / 213卷 / 01期

关键词：

D O I：

10.1097/JU.0000000000004256

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：122 / 123

页数：2

共 50 条

[31] Real-World Application of Pre-Orchiectomy miR-371a-3p Test in Testicular Germ Cell Tumor Management COMMENT
Dieckmann, Klaus-Peter
JOURNAL OF UROLOGY, 2021, 205 (01): : 143 - 144
[32] Real-world application of pre-orchiectomy miR-371a-3p test in testicular germ cell tumor (GCT) management.
Badia, Rohit R.
Abe, Dreaux
Wong, Daniel
Singla, Nirmish
Savelyeva, Anna
Chertack, Nathan
Jia, Liwei
Kapur, Payal
Murray, Matthew
Amatruda, James F.
Lafin, John T.
Bagrodia, Aditya
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
[33] A Multi-institutional Pooled Analysis Demonstrates That Circulating miR-371a-3p Alone is Sufficient for Testicular Malignant Germ Cell Tumor Diagnosis
Piao, Jin
Lafin, John T.
Scarpini, Cinzia G.
Nuno, Michelle M.
Syring, Isabella
Dieckmann, Klaus-Peter
Belge, Gazanfer
Ellinger, Joerg
Amatruda, James F.
Bagrodia, Aditya
Coleman, Nicholas
Krailo, Mark D.
Frazier, A. Lindsay
Murray, Matthew J.
CLINICAL GENITOURINARY CANCER, 2021, 19 (06) : 469 - 479
[34] The combination of microRNA-371a-3p and 375-5p can distinguish viable germ cell tumor and teratoma from necrosis in postchemotherapy retroperitoneal lymph node dissection specimens
Nestler, T.
Kremer, L.
Von Brandenstein, M.
Wittersheim, M.
Koeditz, B.
Paffenholz, P.
Hellmich, M.
Pfister, D.
Heidenreich, A.
EUROPEAN UROLOGY, 2021, 79 : S906 - S906
[35] Viable germ cell tumor and teratoma can be distinguished from necrosis in postchemotherapy retroperitoneal lymph node dissection specimens by a combination of microRNA-371a-3p and 375-5p.
Nestler, Tim
Kremer, Lara
von Brandenstein, Melanie
Koeditz, Barbara
Paffenholz, Pia
Hellmich, Martin
Pfister, David
Heidenreich, Axel
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
[36] THE COMBINATION OF MICRORNA-371A-3P AND 375-5P CAN DISTINGUISH VIABLE GERM CELL TUMOR AND TERATOMA FROM NECROSIS IN POSTCHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION SPECIMENS
Nestler, Tim
Kremer, Lara
von Brandenstein, Melanie
Wittersheim, Maike
Koeditz, Barbara
Paffenholz, Pia
Hellmich, Martin
Pfister, David
Heidenreich, Axel
JOURNAL OF UROLOGY, 2021, 206 : E714 - E714
[37] The combination of microRNA-371a-3p and 375-5p can distinguish viable germ cell tumor and teratoma from necrosis in postchemotherapy retroperitoneal lymph node dissection specimens
Kremer, Lara
von Brandenstein, Melanie
Wittersheim, Maike
Koeditz, Barbara
Paffenholz, Pia
Hellmich, Martin
Pfister, David
Heidenreich, Axel
Nestler, Tim
TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (04)
[38] Plasma miR371 for the detection of viable germ cell tumor in testicular cancer patients with enlarging or post chemotherapy residual nodes.
Nappi, Lucia
Thi, Marisa
Eigl, Bernhard J.
Chi, Kim N.
Gleave, Martin
So, Alan I.
Khalaf, Daniel
Black, Peter C.
Nichols, Craig R.
Kollmannsberger, Christian K.
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
[39] Preservation of ejaculation in patients undergoing nerve-sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer
Pettus, Joseph A.
Carver, Brett S.
Stasi, Jason
Sheinfeld, Joel
JOURNAL OF UROLOGY, 2007, 177 (04): : 278 - 278
[40] Combining Hypermethylated RASSF1A Detection Using ddPCR with miR-371a-3p Testing: An Improved Panel of Liquid Biopsy Biomarkers for Testicular Germ Cell Tumor Patients
Lobo, Joao
van Zogchel, Lieke M. J.
Nuru, Mohammed G.
Gillis, Ad J. M.
van der Schoot, C. Ellen
Tytgat, Godelieve A. M.
Looijenga, Leendert H. J.
CANCERS, 2021, 13 (20)

← 1 2 3 4 5 →